0 Ratings

ID

34560

Description

An Observational Study on Fatigue in Patients With Rheumatoid Arthritis Treated With RoActemra/Actemra (Tocilizumab); ODM derived from: https://clinicaltrials.gov/show/NCT01667458

Link

https://clinicaltrials.gov/show/NCT01667458

Keywords

  1. 1/19/19 1/19/19 -
  2. 2/9/20 2/9/20 - Christian Arras
Copyright Holder

see on clinicaltrials.gov

Uploaded on

January 19, 2019

DOI

To request one please log in.

License

Creative Commons BY-NC 3.0

Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for :

Item comments for :


    No comments

    In order to download data models you must be logged in. Please log in or register for free.

    Eligibility Rheumatoid Arthritis NCT01667458

    Eligibility Rheumatoid Arthritis NCT01667458

    Inclusion Criteria
    Description

    Inclusion Criteria

    Alias
    UMLS CUI
    C1512693
    adult patients, >/= 18 years of age
    Description

    ID.1

    Data type

    boolean

    moderate to severe active rheumatoid arthritis, defined as das28 >/= 3.7
    Description

    ID.2

    Data type

    boolean

    inadequate clinical response to current treatment with >/= 2 non-biologic dmards, 1 of them being methotrexate optimally administered for >/= 3 months, or inadequate clinical response to anti-tnf therapy
    Description

    ID.3

    Data type

    boolean

    eligible for roactemra/actemra treatment in daily clinical practice
    Description

    ID.4

    Data type

    boolean

    absence of evolutive tuberculosis (tb)
    Description

    ID.5

    Data type

    boolean

    Exclusion Criteria
    Description

    Exclusion Criteria

    Alias
    UMLS CUI
    C0680251
    hypersensitivity to tocilizumab or any of the excipients
    Description

    ID.6

    Data type

    boolean

    active, severe infections
    Description

    ID.7

    Data type

    boolean

    pregnant or lactating women
    Description

    ID.8

    Data type

    boolean

    participation in any other interventional study
    Description

    ID.9

    Data type

    boolean

    patients with major depression
    Description

    ID.10

    Data type

    boolean

    Similar models

    Eligibility Rheumatoid Arthritis NCT01667458

    Name
    Type
    Description | Question | Decode (Coded Value)
    Data type
    Alias
    Item Group
    C1512693 (UMLS CUI)
    ID.1
    Item
    adult patients, >/= 18 years of age
    boolean
    ID.2
    Item
    moderate to severe active rheumatoid arthritis, defined as das28 >/= 3.7
    boolean
    ID.3
    Item
    inadequate clinical response to current treatment with >/= 2 non-biologic dmards, 1 of them being methotrexate optimally administered for >/= 3 months, or inadequate clinical response to anti-tnf therapy
    boolean
    ID.4
    Item
    eligible for roactemra/actemra treatment in daily clinical practice
    boolean
    ID.5
    Item
    absence of evolutive tuberculosis (tb)
    boolean
    Item Group
    C0680251 (UMLS CUI)
    ID.6
    Item
    hypersensitivity to tocilizumab or any of the excipients
    boolean
    ID.7
    Item
    active, severe infections
    boolean
    ID.8
    Item
    pregnant or lactating women
    boolean
    ID.9
    Item
    participation in any other interventional study
    boolean
    ID.10
    Item
    patients with major depression
    boolean

    Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

    Watch Tutorial